Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 4.562
-0.084 (-1.81%)
Oct 1, 2026, 5:30 PM CET
Idorsia Market Cap
Idorsia has a market cap or net worth of 1.23 billion as of October 1, 2026. Its market cap has increased by 35.90% in one year.
Market Cap
1.23B
Enterprise Value
2.46B
Revenue
199.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.56
ChartMarket Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 1.23B, a decrease of -24.51%. That is a compound annual growth rate of -2.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.23B | 15.50% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.07B |
| Basilea Pharmaceutica AG | 868.04M |
| Santhera Pharmaceuticals Holding AG | 237.45M |
| Newron Pharmaceuticals | 170.97M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 127.17M |
| Xlife Sciences AG | 56.52M |
| MindMaze Therapeutics Holding | 25.06M |